image
Healthcare - Biotechnology - NASDAQ - US
$ 5.86
-0.509 %
$ 331 M
Market Cap
-3.12
P/E
Price Target Average
320.93%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
20.74%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Astria Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for ATXS of $24.7 , with forecasts ranging from a low of $20 to a high of $29 .
ATXS Lowest Price Target Wall Street Target
20 USD 241.30%
ATXS Average Price Target Wall Street Target
24.7 USD 320.93%
ATXS Highest Price Target Wall Street Target
29 USD 394.88%
Price
Max Price Target
Min Price Target
Average Price Target
303025252020151510105500Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart ATXS

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.02017201720232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ATXS

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)($100.0m)($100.0m)2017201720232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ATXS

image
$500.0m$500.0m$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)($1.5b)($1.5b)($2.0b)($2.0b)($2.5b)($2.5b)($3.0b)($3.0b)2017201720232023202420242025202520262026202720272028202820292029